{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:26:23Z","timestamp":1781821583918,"version":"3.54.5"},"reference-count":46,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/ijo.2016.3534","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T16:10:29Z","timestamp":1464019829000},"page":"479-486","source":"Crossref","is-referenced-by-count":14,"title":["Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells"],"prefix":"10.3892","volume":"49","author":[{"given":"Padmamalini","family":"Thulasiraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Butts","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"key20180107190159_b1-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: Markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107190159_b2-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ejhg.2008.212","article-title":"Breast cancer susceptibility: Current knowledge and implications for genetic counselling","volume":"17","author":"Ripperger","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"key20180107190159_b3-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jbior.2014.09.016","article-title":"Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis","volume":"57","author":"McCubrey","year":"2015","journal-title":"Adv Biol Regul"},{"key":"key20180107190159_b4-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcb.240560108","article-title":"Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?","volume":"56","author":"Kerbel","year":"1994","journal-title":"J Cell Biochem"},{"key":"key20180107190159_b5-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.molonc.2010.04.005","article-title":"Molecular basis for therapy resistance","volume":"4","author":"L\u00f8nning","year":"2010","journal-title":"Mol Oncol"},{"key":"key20180107190159_b6-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/15216540701736285","article-title":"Role of the MRP1\/ABCC1 multidrug transporter protein in cancer","volume":"59","author":"Munoz","year":"2007","journal-title":"IUBMB Life"},{"key":"key20180107190159_b7-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.00035.2005","article-title":"Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins","volume":"86","author":"Deeley","year":"2006","journal-title":"Physiol Rev"},{"key":"key20180107190159_b8-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(05)63876-7","article-title":"Multidrug resistance protein in recurrent breast cancer","volume":"349","author":"Nooter","year":"1997","journal-title":"Lancet"},{"key":"key20180107190159_b9-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-004-0653-9","article-title":"Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: Prognostic implications","volume":"131","author":"Berger","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107190159_b10-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"143202","DOI":"10.1155\/2013\/143202","article-title":"Clinicopathological impact of ABCC1\/MRP1 and ABCC4\/MRP4 in epithelial ovarian carcinoma","volume":"2013","author":"Bagnoli","year":"2013","journal-title":"BioMed Res Int"},{"key":"key20180107190159_b11-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.humpath.2007.10.009","article-title":"Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy","volume":"39","author":"Larbcharoensub","year":"2008","journal-title":"Hum Pathol"},{"key":"key20180107190159_b12-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1155\/2013\/728410","article-title":"MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients","volume":"34","author":"Taheri","year":"2013","journal-title":"Dis Markers"},{"issue":"1A","key":"key20180107190159_b13-ijo-49-02-0479","first-page":"119","article-title":"P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients","volume":"21","author":"Z\u00f6chbauer-M\u00fcller","year":"2001","journal-title":"Anticancer Res"},{"key":"key20180107190159_b14-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade","volume":"18","author":"Kathawala","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key20180107190159_b15-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin cardiomyopathy","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"key20180107190159_b16-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: Function, prognosis and therapy","volume":"9","author":"Kufe","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107190159_b17-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: Protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180107190159_b18-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/oncsis.2013.16","article-title":"MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes","volume":"2","author":"Nath","year":"2013","journal-title":"Oncogenesis"},{"key":"key20180107190159_b19-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7314\/APJCP.2013.14.1.127","article-title":"Effect of MUC1 siRNA on drug resistance of gastric cancer cells to trastuzumab","volume":"14","author":"Deng","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107190159_b20-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1535-6108(04)00020-0","article-title":"Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents","volume":"5","author":"Ren","year":"2004","journal-title":"Cancer Cell"},{"key":"key20180107190159_b21-ijo-49-02-0479","article-title":"Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B","author":"El-Senduny","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180107190159_b22-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000369170","article-title":"Interaction of green tea catechins with breast cancer endocrine treatment: A systematic review","volume":"94","author":"Yiannakopoulou","year":"2014","journal-title":"Pharmacology"},{"key":"key20180107190159_b23-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1745-7254.2005.00164.x","article-title":"Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin","volume":"26","author":"Hu","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107190159_b24-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1745-7254.2008.00725.x","article-title":"Anti-inflammatory effect of honokiol is mediated by PI3K\/Akt pathway suppression","volume":"29","author":"Kim","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107190159_b25-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4155\/fmc.13.32","article-title":"Honokiol analogs: A novel class of anticancer agents targeting cell signaling pathways and other bioactivities","volume":"5","author":"Kumar","year":"2013","journal-title":"Future Med Chem"},{"key":"key20180107190159_b26-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2174\/156652412803833508","article-title":"Honokiol: A novel natural agent for cancer prevention and therapy","volume":"12","author":"Arora","year":"2012","journal-title":"Curr Mol Med"},{"key":"key20180107190159_b27-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol Ther"},{"key":"key20180107190159_b28-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): A review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"key20180107190159_b29-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.179.2.753","article-title":"Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis","volume":"179","author":"Munroe","year":"2007","journal-title":"J Immunol"},{"key":"key20180107190159_b30-ijo-49-02-0479","first-page":"109","article-title":"Chemopreventive effects of combination of honokiol and magnolol with \u03b1-santalol on skin cancer developments","volume":"7","author":"Chilampalli","year":"2013","journal-title":"Drug Discov Ther"},{"key":"key20180107190159_b31-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/cncr.22551","article-title":"Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells","volume":"109","author":"Shigemura","year":"2007","journal-title":"Cancer"},{"key":"key20180107190159_b32-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2005-01-0346","article-title":"Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis","volume":"106","author":"Ishitsuka","year":"2005","journal-title":"Blood"},{"key":"key20180107190159_b33-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180107190159_b34-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3858\/emm.2008.40.6.617","article-title":"Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity","volume":"40","author":"Hu","year":"2008","journal-title":"Exp Mol Med"},{"key":"key20180107190159_b35-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2008.06.026","article-title":"Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer","volume":"591","author":"Liu","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"key20180107190159_b36-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.11.029","article-title":"Down-regulation of c-Src\/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells","volume":"277","author":"Park","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107190159_b37-ijo-49-02-0479","first-page":"911","article-title":"Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1)","volume":"73","author":"Hooijberg","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107190159_b38-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1038\/sj.onc.1206732","article-title":"Human DF3\/MUC1 carcinoma-associated protein functions as an oncogene","volume":"22","author":"Li","year":"2003","journal-title":"Oncogene"},{"key":"key20180107190159_b39-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1038\/sj.onc.1207713","article-title":"MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation","volume":"23","author":"Schroeder","year":"2004","journal-title":"Oncogene"},{"key":"key20180107190159_b40-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1074\/jbc.M310538200","article-title":"The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase\/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts","volume":"279","author":"Raina","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107190159_b41-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-06-4197","article-title":"MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells","volume":"67","author":"Siragusa","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107190159_b42-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14712598.2015.1088519","article-title":"Update on Mucin-1 immunotherapy in cancer: A clinical perspective","volume":"15","author":"Rivalland","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"key20180107190159_b43-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2005.11.031","article-title":"Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7\/ADR by honokiol","volume":"243","author":"Xu","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180107190159_b44-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"e86369","DOI":"10.1371\/journal.pone.0086369","article-title":"Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"key20180107190159_b45-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"e21573","DOI":"10.1371\/journal.pone.0021573","article-title":"Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells","volume":"6","author":"Arora","year":"2011","journal-title":"PLoS One"},{"key":"key20180107190159_b46-ijo-49-02-0479","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1158\/1078-0432.CCR-10-0333","article-title":"Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors","volume":"16","author":"Leeman-Neill","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3534\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:05:30Z","timestamp":1515351930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,5,23]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/ijo.2016.3534"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3534","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}